3 completed, 3 terminated, 2 recruiting, 2 withdrawn. 4 Not applicable, 2 Phase 2, 2 Phase 3, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 2, Terminated 2 |
| Phase 2 | 2 | Withdrawn 2 |
| Phase 3 | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 4 | 1 | Terminated 1 |
Follow Pediatric ulcerative colitis: new trials by email Literature Review of Pediatric ulcerative colitis trials Research Report on Pediatric ulcerative colitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| COMPARE - Pediatric Inflammatory Bowel Disease (PIBD) Ulcerative Colitis, Pediatric, Inflammatory Bowel Diseases | Recruiting | University of North Carolina, Chapel Hill | 1100 | 2025-11-01 | 2026-04-17 | |
| Non-Invasive Monitoring Through Bowel Ultrasound in Paediatric Inflammatory Bowel Disease Study Bowel Ultrasound Scan - Inflammatory Bowel Diseases, Ulcerative Colitis | Unknown | Cardiff and Vale University Health Board | 50 | 2023-05-01 | 2023-08-31 | |
| A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) Mirikizumab - Ulcerative Colitis, Ulcerative Colitis Chronic | Phase 3 | Recruiting | Eli Lilly and Company | 150 | 2021-05-26 | 2026-10-07 |
| Proof of Concept Trial of Vamorolone in Pediatric Ulcerative Colitis Vamorolone 4% suspension for oral dosing - Pediatric Ulcerative Colitis | Phase 1 / Phase 2 | Withdrawn | ReveraGen BioPharma, Inc. | 2020-09-01 | 2020-09-29 | |
| Trial of a Decision Support Intervention for Adolescents and Young Adults With Ulcerative Colitis iBDecide Decision Support Application - Ulcerative Colitis, Pediatric | Not applicable | Completed | Children's Hospital Medical Center, Cincinnati | 42 | 2020-02-07 | 2021-02-04 |
| Peer Mentoring to Improve Self-management in Youth With IBD Group educational activities, IBD educational website, Monthly check-in calls from program coordinator - Pediatric Crohns Disease, Pediatric Ulcerative Colitis | Not applicable | Terminated | Kelly Boone | 79 | 2019-06-12 | 2026-01-13 |
| An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel Disease Infliximab - Inflammatory Bowel Diseases | Phase 4 | Terminated | Janssen Scientific Affairs, LLC | 53 | 2016-04-01 | 2025-02-04 |
| Mission is Remission®: How Can a Disease Self-management Website Change Care? Mission is Remission® - Pediatric Crohn's Disease, Pediatric Ulcerative Colitis | Not applicable | Terminated | IWK Health Centre | 39 | 2016-04-01 | 2019-03-01 |
| Exercise Training in Youth With Inflammatory Bowel Disease Exercise training program - Pediatric Inflammatory Bowel Diseases, Pediatric Crohns Disease | Not applicable | Completed | McMaster University | 11 | 2013-05-01 | 2022-10-24 |
| Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis TA-650 - Pediatric Ulcerative Colitis | Phase 3 | Completed | Tanabe Pharma Corporation | 21 | 2012-02-01 | 2026-01-07 |
| Lactobacillus GG in Pediatric Ulcerative Colitis (UC) Lactobacillus GG - Ulcerative Colitis | Phase 2 | Withdrawn | Children's Hospital Medical Center, Cincinnati | 2011-03-01 | 2017-02-07 |
Inflammatory Bowel Diseases (5) · Colitis, Ulcerative (4) · Crohn Disease (4) · Pediatric Crohn's disease (3)
Digestive System Diseases (7) · Gastroenteritis (7) · Gastrointestinal Diseases (7) · Intestinal Diseases (7) · Colitis (4) · Colonic Diseases (4) · Inflammatory Bowel Diseases (2)
Infliximab (1) · Suspensions (1) · VBP15 compound (1) · mirikizumab (1)
Children's Hospital Medical Center, Cincinnati (2) · Cardiff and Vale University Health Board (1) · Eli Lilly and Company (1) · IWK Health Centre (1) · Janssen Scientific Affairs, LLC (1) · Kelly Boone (1) · McMaster University (1) · ReveraGen BioPharma, Inc. (1) · Tanabe Pharma Corporation (1) · University of North Carolina, Chapel Hill (1)
United States (6) · Canada (3) · Japan (2) · United Kingdom (2) · Austria (1) · Belgium (1) · Brazil (1) · Germany (1) · Israel (1) · Italy (1) · Netherlands (1) · Norway (1) · Poland (1) · Portugal (1) · South Korea (1)
Anthony R Otley, MD MSc (1) · Brian Timmons, PhD (1) · Ellen Lipstein, MD, MPH (1) · Kazuoki Kondo, MD (1) · Laurie Conklin, MD (1) · Lee Denson, M.D. (1) · Martin O Edwards, PhD FRCPCH (1) · Michael D Kappelman, MD (1) · Toshifumi Hibi, MD (1)
PMID 40243391, PMID 31607268, PMID 36161973, PMID 38101846, PMID 40686225
2015 (1)